EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental.

Blood Cancer J

Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

Published: January 2018

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802714	PMC
http://dx.doi.org/10.1038/s41408-017-0045-4	DOI Listing

Publication Analysis

ezh2 mutations

mutations chronic

chronic myelomonocytic

myelomonocytic leukemia

leukemia cluster

cluster asxl1

asxl1 mutations

mutations co-occurrence

co-occurrence prognostically

prognostically detrimental

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!